1174
M. Burian et al.
N-Phenyl-1-(2-oxopiperidin-1-yl)methanesulfonamide (1b, C12H16N2O3S)
Yield 31% (78 mg); mp 124–125ꢄC; 1H NMR (200 MHz, CDCl3): ꢀ ¼ 7.26–7.15 (m, 2H,
m-arom) 6.79–6.72 (m, 3H, o-þp-arom) 4.85 (d, J ¼ 5.0 Hz, SO2CH2) 4.56 (s, NH) 3.33
(t, J ¼ 6.0 Hz, 6-CH2pip) 2.38 (t, J ¼ 5.5 Hz, 3-CH2pip) 1.77–1.71 (m, 4 þ 5-CH2pip) ppm;
13C NMR (50 MHz, CDCl3): ꢀ ¼ 166.65, 137.96, 129.32, 124.76, 120.65, 55.62, 47.38, 38.91,
33.45, 19.22 ppm.
N-Phenyl-1-(2-oxoazepan-1-yl)methanesulfonamide (1c, C13H18N2O3S)
1
Yield 63% (178mg); mp 146–147ꢄC; H NMR (200 MHz, CDCl3): ꢀ ¼ 7.26–7.15 (m, 2H, m-arom)
6.79–6.70 (m, 3H, o-þp-arom) 4.82 (s, SO2CH2) 4.55 (s, NH) 3.37 (t, J ¼ 5.0 Hz, 7-CH2azep) 2.50
(t, J ¼ 6.0 Hz, 3-CH2azep) 1.64–1.47 (m, 4 þ 5 þ 6-CH2azep) ppm; 13C NMR (50 MHz, CDCl3):
ꢀ ¼ 146.13, 129.35, 118.66, 114.01, 57.56, 48.36, 37.56, 29.90, 28.48, 23.31 ppm.
N-(2-Methylphenyl)-1-(2-oxopiperidin-1-yl)methanesulfonamide (1d, C13H18N2O3S)
Yield 45% (127mg); mp 135–138ꢄC; 1H NMR (200 MHz, CDCl3): ꢀ ¼ 7.35–7.18 (m, 4H, arom), 4.85
(d, J ¼ 5.0 Hz, SO2CH2) 4.57 (s, NH) 3.33 (t, J ¼ 6.0 Hz, 6-CH2pip) 2.38 (t, J ¼ 5.5 Hz, 3-CH2pip) 2.32
(s, CH3) 1.77–1.71 (m, 4 þ 5-CH2pip) ppm; 13C NMR (50 MHz, CDCl3): ꢀ ¼ 166.65, 137.96, 129.32,
126.15, 124.76, 120.65, 119.42, 55.62, 47.38, 38.91, 33.45, 19.22, 17.75 ppm.
Bromomethanesulfonyl chloride (4)
Sodium bromomethanesulfonate (3, 19.7 g, 0.1 mol), prepared according to Ref. [6] was mixed with
21.9 g PCl5 (0.105 mol). A spontaneous exothermal reaction immediately started and after its
finishing (10–15 min), the reaction mixture was heated 45 min at 130–140ꢄC and additional
30 min at 70ꢄC. The reaction product was obtained by distillation at reduced pressure, bp 93–
1
95ꢄC=2.7 kPa (Ref. [7] 87–89ꢄC=2.0 kPa), yield 79% (15.3 g); H NMR (200 MHz, DMSO-d6):
ꢀ ¼ 5.11 (s, CH2) ppm.
N-Phenyl-1-bromomethanesulfonamides 5
Bromomethanesulfonyl chloride (4, 3.9g, 0.02mol) dissolved in 10cm3 toluene were dropwise added
to a stirred solution of 0.04 mol aniline or 2-methylaniline during 15min. The resulting reaction
mixture was refluxed for 5 h, then cooled, and the precipitate of anilinium chloride was filtered off.
The filtrate was extracted with 3% aqu HCl and H2O and then the desired 5 was extracted into 3%
NaOH solution. The alkaline H2O extract was acidified with HCl to pH ¼ 1 and the precipitated
product was isolated by filtration.
N-Phenyl-1-bromomethanesulfonamide (5a, C7H8NO2SBr)
Yield 50% (1.4 g); 1H NMR (200 MHz, DMSO-d6): ꢀ ¼ 10.34 (s, NH) 7.38–7.13 (m, 5H,
arom) 4.90 (s, CH2) ppm; 13C NMR (50 MHz, DMSO-d6): ꢀ ¼ 137.17, 129.13, 124.26, 120.38,
41.28 ppm.
N-(2-Methylphenyl)-1-bromomethanesulfonamide (5b, C8H10NO2SBr)
1
Yield 38% (2.0g); H NMR (200 MHz, DMSO-d6): ꢀ ¼ 9.65 (s, NH) 7.33–7.16 (m, 4H, arom) 4.88
(s, CH2) 2.33 (s, CH3) ppm; 13C NMR (DMSO-d6): ꢀ ¼ 134.73, 134.46, 130.67, 126.72, 126.41, 42.42,
17.99 ppm.
Oxidation of 1 with t-BuOOH=PbO2
Sulfonamides 1 were dissolved in a 0.01M benzene solution of t-BuOOH in a molar ratio
1=t-BuOOH ¼ 1=1. In 2 cm3 of this solution 10mg PbO2 were suspended and stirred for 1 min. After
the sedimentation of solid PbO2, 0.5 cm3 of the liquid phase were transferred into an EPR tube
(ø ¼ 5 mm), bubbled with N2, and measured.